<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">Echinaforce® is a standardized preparation extracted from freshly harvested herb (herba tintura 2580 mg/125 drops) and roots (radix tintura 135 mg/125 drops) of 
 <italic>Echinacea purpurea</italic> (L.) Moench plants (purple coneflower) with a 65% alcoholic solution (Schapowal 
 <xref ref-type="bibr" rid="CR102">2020</xref>). Echinaforce® reduces the infectivity of HCoV-229E in a dose-dependent manner. It inhibits HCoV-229E infection of respiratory epithelial cells (Schapowal 
 <xref ref-type="bibr" rid="CR102">2020</xref>). HCoV-229E was irreversibly inactivated when exposed to Echinaforce® (IC
 <sub>50</sub> of 3.2 μg/ml) (Schapowal 
 <xref ref-type="bibr" rid="CR102">2020</xref>). Echinaforce® showed a dose-dependent reduction of HCoV 229E infectivity with an IC
 <sub>50</sub> = 9 ± 3 μg/ml (Engler et al. 
 <xref ref-type="bibr" rid="CR31">2017</xref>). Complete neutralization was achieved with 50 μg/ml (Engler et al. 
 <xref ref-type="bibr" rid="CR31">2017</xref>).
</p>
